论文部分内容阅读
目的采用手术及介入两种方法治疗晚期肝门部胆管癌,对比其临床效果。方法 95例肝门部胆管癌患者,根据治疗方法不同分为手术组(46例)及介入组(49例),分别给予手术及介入治疗,并比较两组总胆红素、存活时间、治疗时间及费用、并发症情况。结果两组患者治疗后总胆红素含量与治疗前比较均明显降低(P<0.05),但组间比较差异无统计学意义(P>0.05);两组存活情况比较差异无统计学意义(P>0.05);介入组治疗时间及费用均优于手术组(P<0.05);介入组并发症发生率(8.16%)低于手术组(23.91%),但差异无统计学意义(P>0.05)。结论采用介入治疗方法对晚期肝门部胆管癌进行治疗,在保证治疗效果与常规手术治疗基本相同的条件下,降低了治疗费用及时间,且并发症发生率较低,可作为优选治疗方法进行推广。
Objective To investigate the clinical effects of two methods of operation and intervention in the treatment of advanced hilar cholangiocarcinoma. Methods Ninety - five patients with hilar cholangiocarcinoma were divided into operation group (n = 46) and intervention group (n = 49) according to different treatment methods. The patients were given operation and interventional treatment respectively. The total bilirubin, survival time, Time and costs, complications. Results The total bilirubin levels in both groups were significantly lower than those before treatment (P <0.05), but there was no significant difference between the two groups (P> 0.05). There was no significant difference in survival between the two groups P> 0.05). The intervention time and cost were better in the intervention group than those in the operation group (P <0.05). The incidence of complications in the intervention group (8.16%) was lower than that in the operation group (23.91%), but the difference was not statistically significant (P> 0.05). Conclusion The treatment of advanced hilar cholangiocarcinoma by interventional therapy can reduce the cost and time of treatment under the condition that the treatment effect is basically the same as that of conventional surgical treatment, and the complication rate is low, which can be used as the preferred treatment method Promotion.